Lipigon Pharmaceuticals AB
F:9RP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lipigon Pharmaceuticals AB
F:9RP
|
SE |
|
M
|
Megado Gold Ltd
ASX:MEG
|
AU |
|
K
|
KD Corp
KOSDAQ:044180
|
KR |
|
A
|
Asia Network International PCL
SET:ANI
|
TH |
|
I
|
Italian Design Brands SpA
MIL:IDB
|
IT |
|
V
|
Virtu Financial Inc
F:0VF
|
US |
|
O
|
Ossur hf
OTC:OSSFF
|
IS |
|
International Petroleum Corp
OTC:IPCFF
|
CA |
|
Steppe Gold Ltd
OTC:STPGF
|
MN |
Shareholder Yield
Current shareholder yield for 9RP is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
9RP Price
Lipigon Pharmaceuticals AB
| Average Annual Return | -66.43% |
| Standard Deviation of Annual Returns | 34.5% |
| Max Drawdown | -100% |
| Market Capitalization | 908.9k EUR |
| Shares Outstanding | 333 425 684 |
| Percentage of Shares Shorted |
N/A
|
